Cargando…
Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2
Amyotrophic lateral sclerosis is a fatal neurodegenerative disease causing upper and lower motor neuron loss and currently no effective disease-modifying treatment is available. A pathological feature of this disease is neuroinflammation, a mechanism which involves both CNS-resident and peripheral i...
Autores principales: | Giovannelli, Ilaria, Bayatti, Nadhim, Brown, Abigail, Wang, Dennis, Mickunas, Marius, Camu, William, Veyrune, Jean-Luc, Payan, Christine, Garlanda, Cecilia, Locati, Massimo, Juntas-Morales, Raul, Pageot, Nicolas, Malaspina, Andrea, Andreasson, Ulf, Suehs, Carey, Saker, Safa, Masseguin, Christophe, de Vos, John, Zetterberg, Henrik, Al-Chalabi, Ammar, Leigh, P Nigel, Tree, Timothy, Bensimon, Gilbert, Heath, Paul R, Shaw, Pamela J, Kirby, Janine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364666/ https://www.ncbi.nlm.nih.gov/pubmed/34409288 http://dx.doi.org/10.1093/braincomms/fcab141 |
Ejemplares similares
-
Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial
por: Camu, William, et al.
Publicado: (2020) -
High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study
por: Juntas-Morales, Raul, et al.
Publicado: (2020) -
Dietary BMAA Exposure in an Amyotrophic Lateral Sclerosis Cluster from Southern France
por: Masseret, Estelle, et al.
Publicado: (2013) -
Low 25OH Vitamin D Blood Levels Are Independently Associated With Higher Amyotrophic Lateral Sclerosis Severity Scores: Results From a Prospective Study
por: Juntas-Morales, Raul, et al.
Publicado: (2020) -
Comparison of Blood RNA Extraction Methods Used for Gene Expression Profiling in Amyotrophic Lateral Sclerosis
por: Bayatti, Nadhim, et al.
Publicado: (2014)